Answers are grounded in this paper and cite their sources.
Background Coronary atherosclerotic heart disease is a major cardiovascular disease that poses a serious threat to human health. Quinazoline derivatives possess diverse biological activities and considerable structural modifiability, making them valuable candidates for drug development. Objective This study aimed to investigate the potential mechanism by which the novel 2-trifluoromethyl-4-aminoquinazoline derivative KZL-064 protects against vascular endothelial injury. Methods Network pharmacology, single-cell transcriptomic analysis, and functional experiments were integrated to identify and prioritize a candidate functional target of KZL-064. An oscillatory shear stress-induced endothelial cell injury model was established to evaluate the protective effects of KZL-064. The functional involvement of the candidate target was further examined through HDAC1 overexpression and knockdown experiments. Results HDAC1 was identified as a prioritized candidate functional target potentially associated with the effects of KZL-064 and was significantly upregulated in atherosclerotic lesions. HDAC1 overexpression aggravated endothelial injury, whereas KZL-064 markedly alleviated oscillatory shear stress-induced damage. This protective effect was substantially diminished following HDAC1 knockdown. Further analysis indicated that KZL-064 was associated with the partial restoration of endothelial homeostasis and the modulation of inflammatory and cell cycle-related genes in an HDAC1-related context. Conclusion KZL-064 alleviates OSS-induced endothelial cell injury and is associated with modulation of inflammatory and cell cycle-related genes. HDAC1 was identified as a prioritized candidate functional target potentially involved in the action of KZL-064. These findings suggest potential relevance to atherosclerosis-associated endothelial dysfunction, while direct HDAC1 binding, enzymatic inhibition, target selectivity, and in vivo anti-atherosclerotic efficacy remain to be established.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: